
|Articles|October 10, 2018
PAREXEL Announces New Patient-Centric Innovations to Address Drug Development Challenges
Advertisement
PAREXEL International Corporation, a provider of global biopharmaceutical services, announced that it has developed new solutions that take a patient-centric approach to addressing drug development. These solutions were built on the Perceptive Cloud platform in hopes to leverage mobile and wearable technology.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement